Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00303888
Status:
TERMINATED
Last Update Posted:
2018-01-17
First Post:
2006-03-15
Brief Title:
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cavity Cancer
Sponsor:
Yale University
Organization:
Yale University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cavity Cancer |
| Fallopian Tube Cancer |
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV fallopian tube cancer | View |
| recurrent ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| stage IIIA ovarian epithelial cancer | View |
| stage IIIB ovarian epithelial cancer | View |
| stage IIIC ovarian epithelial cancer | View |
| recurrent primary peritoneal cavity cancer | View |
| stage IIIA primary peritoneal cavity cancer | View |
| stage IIIB primary peritoneal cavity cancer | View |
| stage IIIC primary peritoneal cavity cancer | View |
| stage IV primary peritoneal cavity cancer | View |
| recurrent fallopian tube cancer | View |
| stage IIIA fallopian tube cancer | View |
| stage IIIB fallopian tube cancer | View |
| stage IIIC fallopian tube cancer | View |